LifeStance Health
LFST
12.11
-0.01
-0.08%
LifeStance Health
US · LFST
#2190 by market cap
Listed 2021
12.11
-0.01
-0.08%
Live - 5344 symbols - heartbeat 345s ago
· 2026-10-08 07:36
Pre-market
12.31
+1.65%
After-hours
12.33
+1.82%
- Market cap
- 4.60B
- P/E (TTM)i
- 93.15
- P/Bi
- 3.12
- EPSi
- 0.02
- Div yieldi
- 0.00%
- 52W posi
- 84%
Reader sentiment
Are you bullish or bearish on LFST?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
J.P. Morgan Maintains LifeStance Health(LFST.US) With Hold Rating, Raises Target Price to $13Market Newswire · 2026/8/14
-
Rating change
KeyBanc Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $13Market Newswire · 2026/7/13
-
Rating change
CCORF Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $13Market Newswire · 2026/7/22
-
Rating change
Jefferies Initiates LifeStance Health(LFST.US) With Buy Rating, Announces Target Price $14Market Newswire · 2026/7/17
-
Rating change
Barclays Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $13Market Newswire · 2026/8/11
-
Rating change
BTIG Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $16Market Newswire · 2026/8/8
-
Jefferies Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2026/9/25
-
Rating change
William Blair Maintains LifeStance Health(LFST.US) With Buy RatingMarket Newswire · 2026/8/21
-
Rating change
BTIG Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2026/7/24
-
CCORF Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2026/9/9
-
Company notice
LifeStance Health: LifeStance Health Group, Inc. - Flex Position Consolidations Option Symbol: 1LFSTOCC · 2024/10/22
-
Rating change
Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $13Market Newswire · 2026/8/7
-
BTIG Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $18Market Newswire · 2026/8/19
-
Rating change
CCORF Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $13Market Newswire · 2026/8/8
-
Barclays Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2026/9/10
-
Rating change
A Quick Look at Today's Ratings for LifeStance Health(LFST.US), With a Forecast Between $13 to $16Market Newswire · 2026/8/7
-
Rating change
Barclays Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $13Market Newswire · 2026/7/14
-
Rating change
J.P. Morgan Sticks to Its Hold Rating for Lifestance Health Group (LFST)TipRanks · 2026/8/14
-
KeyBanc Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2026/10/5
-
Rating change
Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $13Market Newswire · 2026/8/12
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 07:36:38 · For reference only, not investment advice and not tailored to your situation.